19428-14-9
基本信息
磷酸苯丙哌林
磷酸苯丙哌啉
BENPROPERINE PHOSPHATE
BENPROPERINE PHOSPHATE CP2000
1-(2-Benzylphenoxy)-2-piperidinopropane phosphate
1-[2-(2-Benzylphenoxy)-1-methylethyl]piperidine monophosphate
ASA 158-5
Blascorid
Piperidine, 1-[1-methyl-2-[(a-phenyl-o-tolyl)oxy]ethyl]-, phosphate (1:1) (8CI)
Piperidine, 1-[1-methyl-2-[2-(phenylmethyl)phenoxy]ethyl]-, phosphate (1:1)
Flaveric
物理化学性质
熔点 | 150-152° |
储存条件 | Refrigerator |
溶解度 | DMSO(微溶,加热)、甲醇(微溶) |
形态 | 固体 |
颜色 | 白色至灰白色 |
InChI | InChI=1S/C21H27NO.H3O4P/c1-18(22-14-8-3-9-15-22)17-23-21-13-7-6-12-20(21)16-19-10-4-2-5-11-19;1-5(2,3)4/h2,4-7,10-13,18H,3,8-9,14-17H2,1H3;(H3,1,2,3,4) |
InChIKey | MCVUURBOSHQXMK-UHFFFAOYSA-N |
SMILES | C1(C=CC=CC=1OCC(C)N1CCCCC1)CC1=CC=CC=C1.P(=O)(O)(O)O |
CAS 数据库 | 19428-14-9(CAS DataBase Reference) |
安全数据
危险性符号(GHS) | GHS07 |
警示词 | 警告 |
危险性描述 | H302-H315-H319-H335 |
防范说明 | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
毒性 | LD50 orally in mice: 1431 mg/kg (Tellini, De Fina) |
常见问题列表
(1) 中枢性镇咳药能够抑制延髓咳嗽中枢而产生镇咳作用,包括成瘾性镇咳药如可待因和非成瘾性镇咳药如右美沙芬、喷托维林等。
(2) 外周性镇咳药是通过抑制咳嗽反射弧中感受器、传入神经或传出神经中任何一个环节而发挥镇咳作用,如苯哌丙烷、咳快好、苯丙哌林、咳福乐、二苯哌丙烷等。
需要注意的是,镇咳药仅仅能够缓解咳嗽,但不能消除导致咳嗽的病因,只有结合病因治疗才能达到治疗的目的。无痰的干咳宜选用可待因、喷托维林或右美沙芬等药物。急性上呼吸道感染、慢性支气管炎等因素引起的咳嗽则宜选用磷酸苯丙哌林等药物。
磷酸苯丙哌林是非麻醉性镇咳药苯丙哌林的磷酸盐,外观呈白色结晶粉末,微带特臭,味苦。易溶于水、甲醇、乙酸,略溶于氯仿或苯,几乎不溶于乙醇、丙酮和乙醚。本品具有较强镇咳作用,奏效迅速,动物实验证明此药的镇咳效力比可待因强2~4倍。本品除抑制咳嗽中枢外,尚可阻断肺-胸膜的牵张感受器产生的肺-迷走神经反射,并具有罂粟碱样平滑肌解痉作用,故其镇咳作用兼具中枢性和末梢性双重机制。本品不抑制呼吸,不引起胆道及十二指肠痉挛或收缩,不引起便秘,且毒性较低,未发现耐受性及成瘾性。临床用于治疗急性支气管炎及各种原因如感染、吸烟、刺激物、过敏等引起的咳嗽,上呼吸道炎症(咽炎、鼻炎)吸烟过敏等引起的咳嗽,对刺激性干咳效佳。口服后15~60分钟内起效,持续时间为4~7小时。成人口服,每次20~40mg,1日60~120mg。也可根据病情决定。磷酸苯丙哌林副作用少,偶见口干、舌尖麻木、胃部烧灼感、食欲不振、乏力、头晕和药疹等不良反应。对本品过敏者禁用。孕妇应在医师指导下应用。
Benproperine phosphate (20-120 μM; for 24 hours) inhibits cell viability in a dose-dependent manner.
Benproperine phosphate (10 μM; for 24 hours) significantly inhibits the migration of various types of cancer cells and inhibits the migration and invasion of DLD-1, AsPC-1 cells with IC
50
values of 1-2 μM. Benproperine phosphate (10 μM; for 24 hours) does not affect cortactin-rich lamellipodium in MCF-10A cells.
Cell Viability Assay
Cell Line: | DLD-1, AsPC-1, CFPAC-1, A375P, A375P, MDA-MB-231, DU145, DU145 cancer cells |
Concentration: | 20, 40, 60, 80, 100, 120 μM |
Incubation Time: | For 24 hours |
Result: | Inhibited cell viability in a dose-dependent manner. |
Benproperine phosphate (50, 100 mg/kg; oral gavage; 5 days per week for 4 weeks) inhibits primary pancreatic tumor growth.
Benproperine phosphate shows a marked decrease in the lung metastasis of AsPC-1 cells (56.1% inhibition) in mouse. Benproperine phosphate significantly suppressed the liver metastasis of HCT-116 cells by 78.9% and DLD-1 cells by 78.2%.
Animal Model: | Female BALB/c nude mice of 6-week-old with AsPC-1 cells |
Dosage: | 50, 100 mg/kg |
Administration: | Oral gavage; 5 days per week for 4 weeks |
Result: | Inhibited primary pancreatic tumor growth compared to the vehicle control (47.7% inhibition) without body weights change. |
磷酸苯丙哌林价格(试剂级)
报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
2024/11/08 | HY-114657A | 磷酸苯丙哌林 Benproperine phosphate | 19428-14-9 | 100mg | 500元 |
2024/11/08 | HY-114657A | 磷酸苯丙哌林 Benproperine phosphate | 19428-14-9 | 10mM * 1mLin DMSO | 550元 |
2024/11/08 | S5256 | 磷酸苯丙哌林 Benproperine phosphate | 19428-14-9 | 10mg | 574.13元 |